Rio Silver Inc. ("Rio Silver" or the "Company") is pleased to announce that it has settled an aggregate of $293,250 of indebtedness (the "Debts") through (1) the issuance of an aggregate of 1,396,428 ...
In the rapidly evolving landscape of modern biotechnology, the precision of molecular tools determines the speed of medical breakthroughs. As a Global Leading Biotinylated Peptide Synthesis specialist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback